Literature DB >> 19666194

Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults. V. Complementary and alternative medicine treatments.

Arun V Ravindran1, Raymond W Lam, Marie J Filteau, François Lespérance, Sidney H Kennedy, Sagar V Parikh, Scott B Patten.   

Abstract

BACKGROUND: In 2001, the Canadian Psychiatric Association and the Canadian Network for Mood and Anxiety Treatments (CANMAT) partnered to produce evidence-based clinical guidelines for the treatment of depressive disorders. A revision of these guidelines was undertaken by CANMAT in 2008-2009 to reflect advances in the field. There is widespread interest in complementary and alternative medicine (CAM) therapies in the treatment of major depressive disorder (MDD).
METHODS: The CANMAT guidelines are based on a question-answer format to enhance accessibility to clinicians. An evidence-based format was used with updated systematic reviews of the literature and recommendations were graded according to Level of Evidence using pre-defined criteria. Lines of Treatment were identified based on criteria that included evidence and expert clinical support. This section on "Complementary and Alternative Medicine Treatments" is one of 5 guideline articles.
RESULTS: There is Level 1 evidence to support light therapy in seasonal MDD and St. John's wort in mild to moderate MDD. There is also some evidence for the use of exercise, yoga and sleep deprivation, as well as for omega-3 fatty acids and SAM-e . Support for other natural health products and therapies is still limited. LIMITATIONS: The evidence base remains limited and studies often have methodological problems, including small samples, variability in dose, short duration of treatment, unknown quality of the agent and limited long-term data. Safety data are also sparse with little information about drug interactions.
CONCLUSIONS: Some CAM treatments have evidence of benefit in MDD. However, problems with standardization and safety concerns may limit their applicability in clinical practice.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19666194     DOI: 10.1016/j.jad.2009.06.040

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  23 in total

Review 1.  Internet-delivered cognitive behavioural therapy in the treatment of psychiatric illness.

Authors:  David Gratzer; Faiza Khalid-Khan
Journal:  CMAJ       Date:  2015-11-02       Impact factor: 8.262

2.  Women with depression should be offered folic acid.

Authors:  Jonathan Melong; David Gardner
Journal:  Can Fam Physician       Date:  2011-09       Impact factor: 3.275

Review 3.  Efficacy and acceptability of pharmacological treatments for depressive disorders in primary care: systematic review and network meta-analysis.

Authors:  Klaus Linde; Levente Kriston; Gerta Rücker; Susanne Jamil; Isabelle Schumann; Karin Meissner; Kirsten Sigterman; Antonius Schneider
Journal:  Ann Fam Med       Date:  2015 Jan-Feb       Impact factor: 5.166

Review 4.  Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 5. Complementary and Alternative Medicine Treatments.

Authors:  Arun V Ravindran; Lynda G Balneaves; Guy Faulkner; Abigail Ortiz; Diane McIntosh; Rachel L Morehouse; Lakshmi Ravindran; Lakshmi N Yatham; Sidney H Kennedy; Raymond W Lam; Glenda M MacQueen; Roumen V Milev; Sagar V Parikh
Journal:  Can J Psychiatry       Date:  2016-08-02       Impact factor: 4.356

Review 5.  The dominance behavioral system and psychopathology: evidence from self-report, observational, and biological studies.

Authors:  Sheri L Johnson; Liane J Leedom; Luma Muhtadie
Journal:  Psychol Bull       Date:  2012-04-16       Impact factor: 17.737

Review 6.  Systematic Review of Clinical Practice Guidelines for Failed Antidepressant Treatment Response in Major Depressive Disorder, Dysthymia, and Subthreshold Depression in Adults.

Authors:  Glenda MacQueen; Pasqualina Santaguida; Homa Keshavarz; Natalia Jaworska; Mitchell Levine; Joseph Beyene; Parminder Raina
Journal:  Can J Psychiatry       Date:  2016-09-24       Impact factor: 4.356

Review 7.  Wake-promoting pharmacotherapy for psychiatric disorders.

Authors:  Bernardo Dell'Osso; Cristina Dobrea; Laura Cremaschi; Chiara Arici; A Carlo Altamura
Journal:  Curr Psychiatry Rep       Date:  2014-12       Impact factor: 5.285

8.  Depression, Comorbidities, and Prescriptions of Antidepressants in a German Network of GPs and Specialists with Subspecialisation in Anthroposophic Medicine: A Longitudinal Observational Study.

Authors:  Elke Jeschke; Thomas Ostermann; Horst C Vollmar; Manuela Tabali; Harald Matthes
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-06       Impact factor: 2.629

9.  Mood disorders and complementary and alternative medicine: a literature review.

Authors:  Naseem Akhtar Qureshi; Abdullah Mohammed Al-Bedah
Journal:  Neuropsychiatr Dis Treat       Date:  2013-05-14       Impact factor: 2.570

10.  Direct health care costs of treating seasonal affective disorder: a comparison of light therapy and fluoxetine.

Authors:  Amy Cheung; Carolyn Dewa; Erin E Michalak; Gina Browne; Anthony Levitt; Robert D Levitan; Murray W Enns; Rachel L Morehouse; Raymond W Lam
Journal:  Depress Res Treat       Date:  2012-10-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.